CLINICAL_TRIALS
withdrawal
· 2025-05-16
Clinical Trial Update: Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia [Phase 2]
Summary
Phase 2 trial evaluating laryngeal vibro-tactile stimulation for spasmodic dysphonia has been withdrawn. The sponsor is University of Minnesota and the conditio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Minnesota | Conditions: Adductor Spasmodic Dysphonia, Abductor Spastic Dysphonia | Phase 2 | Status: WITHDRAWN